Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
<h4>Background</h4>Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypoth...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4ba9869d8b5847e4bc8c9d438436d256 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4ba9869d8b5847e4bc8c9d438436d256 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4ba9869d8b5847e4bc8c9d438436d2562021-11-18T07:46:40ZPlasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.1932-620310.1371/journal.pone.0062741https://doaj.org/article/4ba9869d8b5847e4bc8c9d438436d2562013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23667516/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations.<h4>Methods</h4>We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events.<h4>Results</h4>Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 ± 0.11 vs. 0.36 ± 0.14 ng/ml, p = 0.01), 2-AG (8.93 ± 3.20 vs. 6.26±2.10 ng/ml, p<0.01), OEA (5.90 ± 2.10 vs. 3.88 ± 1.85 ng/ml, p<0.01), SEA (2.70 ± 3.37 vs. 0.83 ± 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 ± 0.05 vs. 0.45 ± 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 ± 3.20 vs. 6.01 ± 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 ± 1.87 vs. 2.63±1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations.<h4>Conclusions</h4>PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts.Daniela HauerGustav SchellingHannah GolaPatrizia CampolongoJulia MorathBenno RoozendaalGilava HamuniAlexander KarabatsiakisPiray AtsakMichael VogeserIris-Tatjana KolassaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 5, p e62741 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Daniela Hauer Gustav Schelling Hannah Gola Patrizia Campolongo Julia Morath Benno Roozendaal Gilava Hamuni Alexander Karabatsiakis Piray Atsak Michael Vogeser Iris-Tatjana Kolassa Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| description |
<h4>Background</h4>Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations.<h4>Methods</h4>We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events.<h4>Results</h4>Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 ± 0.11 vs. 0.36 ± 0.14 ng/ml, p = 0.01), 2-AG (8.93 ± 3.20 vs. 6.26±2.10 ng/ml, p<0.01), OEA (5.90 ± 2.10 vs. 3.88 ± 1.85 ng/ml, p<0.01), SEA (2.70 ± 3.37 vs. 0.83 ± 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 ± 0.05 vs. 0.45 ± 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 ± 3.20 vs. 6.01 ± 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 ± 1.87 vs. 2.63±1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations.<h4>Conclusions</h4>PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts. |
| format |
article |
| author |
Daniela Hauer Gustav Schelling Hannah Gola Patrizia Campolongo Julia Morath Benno Roozendaal Gilava Hamuni Alexander Karabatsiakis Piray Atsak Michael Vogeser Iris-Tatjana Kolassa |
| author_facet |
Daniela Hauer Gustav Schelling Hannah Gola Patrizia Campolongo Julia Morath Benno Roozendaal Gilava Hamuni Alexander Karabatsiakis Piray Atsak Michael Vogeser Iris-Tatjana Kolassa |
| author_sort |
Daniela Hauer |
| title |
Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| title_short |
Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| title_full |
Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| title_fullStr |
Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| title_full_unstemmed |
Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| title_sort |
plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/4ba9869d8b5847e4bc8c9d438436d256 |
| work_keys_str_mv |
AT danielahauer plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT gustavschelling plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT hannahgola plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT patriziacampolongo plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT juliamorath plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT bennoroozendaal plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT gilavahamuni plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT alexanderkarabatsiakis plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT pirayatsak plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT michaelvogeser plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder AT iristatjanakolassa plasmaconcentrationsofendocannabinoidsandrelatedprimaryfattyacidamidesinpatientswithposttraumaticstressdisorder |
| _version_ |
1718422968045928448 |